Charlie C. Hu

Fibroblast growth factor 21 corrects obesity in mice.

D. Moller, Yanyun Chen, T. Coşkun, 2008, Endocrinology.

Pharmacological Evaluation of a Pegylated Urocortin-1 Peptide in Experimental Autoimmune Disease Models

K. Thirunavukkarasu, Charlie C Hu, Y. Ma, 2022, The Journal of Pharmacology and Experimental Therapeutics.

Assessment of Diet‐induced Obese Rats as an Obesity Model by Comparative Functional Genomics

S. Estrem, J. Calley, E. Dow, 2008, Obesity.

Diet-induced changes in stearoyl-CoA desaturase 1 expression in obesity-prone and -resistant mice.

K. Qing, Yanyun Chen, Charlie C. Hu, 2004, Obesity research.

A selective GPR40 (FFAR1) agonist LY2881835 provides immediate and durable glucose control in rodent models of type 2 diabetes

A. R. Miller, S. D. Kahl, D. Scheuner, 2016, Pharmacology research & perspectives.

A Novel Nociceptin Receptor Antagonist LY2940094 Inhibits Excessive Feeding Behavior in Rodents: A Possible Mechanism for the Treatment of Binge Eating Disorder

J. Pintar, M. Ansonoff, J. Witkin, 2016, The Journal of Pharmacology and Experimental Therapeutics.

Development of a long‐acting relaxin analogue, LY3540378, for treatment of chronic heart failure

Matthew M. Abernathy, R. Hansen, M. C. Carr, 2023, British journal of pharmacology.

A Novel Nociceptin Receptor Antagonist LY2940094 Inhibits Excessive Feeding Behavior in Rodents: A Possible Mechanism for the Treatment of Binge Eating Disorder

J. Pintar, M. Ansonoff, J. Witkin, 2016, The Journal of Pharmacology and Experimental Therapeutics.